Prevalence of severe adverse events among health professionals after receiving the first dose of the ChAdOx1 nCoV-19 coronavirus vaccine (Covishield) in Togo, March 2021

Prevalence of severe adverse events among health professionals after receiving the first dose of the ChAdOx1 nCoV-19 coronavirus vaccine (Covishield) in Togo, March 2021

Abstract Background The coronavirus disease 2019 (COVID-19) vaccines can cause adverse events that can lead to vaccine hesitancy. This study aims at estimating the prevalence of severe adverse events (SAEs) and their associated factors among health professionals vaccinated with ChAdOx1 nCoV-19 vacci...

Full description

Bibliographic Details
Main Authors: Yao Rodion Konu, Fifonsi Adjidossi Gbeasor-Komlanvi, Mouhoudine Yerima, Arnold Junior Sadio, Martin Kouame Tchankoni, Wendpouire Ida Carine Zida-Compaore, Josée Nayo-Apetsianyi, Kossivi Agbélénko Afanvi, Sibabe Agoro, Mounerou Salou, Dadja Essoya Landoh, Atany B. Nyansa, Essohanam Boko, Moustafa Mijiyawa, Didier Koumavi Ekouevi
Format: Article
Language:English
Published: BMC 2021-11-01
Series:Archives of Public Health
Subjects:
Adverse event
ChAdOx1 nCoV-19
COVID-19
Vaccine
Health professionals
Togo
Online Access:https://doi.org/10.1186/s13690-021-00741-x

Similar Items

Similar Items